Search Results

63 results

  1. CORESTA Congress, Online, 2020, Smoke Science/Product Technology Groups, ST 03

    Method development for the analysis of mono-carbonyl compounds in e-vapor products by LC-MS

    ZHU J.; HEREDIA A.; TWEEDY J.; TAYYARAH R.
    ITG Brands and Fontem USA, Greensboro, NC, U.S.A.
    At the 73rd Tobacco Science Research Conference (TSRC), we presented a novel method for quantitation by LC-MS of mono-carbonyl compounds in e-vapor product aerosol samples. The method is simple and robust with good recoveries. We have since extended...
  2. CORESTA Meeting, Smoke Science/Product Technology, 2019, Hamburg, ST 21

    A model based on cigarette density segmentation method for predicting burning cone drop rate of slim cigarettes

    TAN Chao; WANG Shitai; JIN Yong; CHEN Qian; TAN Haifeng; LI Ke; FAN Hongmei; LIU Qi; LI Rui; YU Saibo
    China Tobacco Hunan Industrial Co., Ltd. of CNTC, Hunan, P.R. China
    Burning cone drop is a potential safety problem and quality defect for slim cigarettes. In order to conveniently monitor the burning cone drop rate, a model based on cigarette density segmentation method was established and used for predicting the...
  3. CORESTA Meeting, Smoke Science/Product Technology, 2019, Hamburg, ST 45

    Meta-analysis of two biomarkers of exposure of tobacco products

    AYALA-FIERRO F.(1); ELAMIN A.(2); FROST-PINEDA K.(3); JIN T.(3); PRASAD G.L.(3); SARKAR M.(4); SCHMIDT E.(3); VERRON T.(5)
    (1) ITG Brands LLC, Greensboro, NC, U.S.A.; (2) PMI R&D, Philip Morris Products S.A., Neuchâtel, Switzerland; (3) RAI Services Company, Winston-Salem, NC, U.S.A.; (4) Altria Client Services LLC, Richmond, VA, U.S.A.; (5) SEITA - Imperial Brands, Paris, France
    In the context of tobacco products, broadly two types of biomarkers exist, biomarkers of exposure (BoE) and biomarkers of potential harm (BoPH). BoE measure exposure to tobacco constituents, e.g. carbon monoxide (CO) and nicotine equivalents (NEQs)....
  4. TSRC, Tob. Sci. Res. Conf., 2019, 73, abstr. 042

    Determination of amounts of harmful substances migrating from plastic assemblies in electronic cigarettes

    FAN Meijuan(1); PAN Lining(1); CUI Huapeng(1); DUAN Yuanxing(2); LIU Yibo(3); NIU Jiajia(1); MAO Youan(4); CHEN Li(1); GUO Junwei(1); LIU Shaofeng(1); WANG Hongbo(1); LIU Huimin(1); ZHAO Le(1)
    (1) Zhengzhou Tobacco Research Institute of CNTC, Zhengzhou, P.R. China; (2) Technology Center of China Tobacco Yunnan Industrial, Kunming, P.R. China; (3) Technology Center of China Tobacco Guangdong Industrial, Guangzhou, P.R. China; (4) Technology Center of China Tobacco Hunan Industrial, Changsha, P.R. China
    Plastic materials are widely used in assemblies of e-cigarettes. Plastic materials shall not transfer harmful substances to the content of e-liquid in quantities which change the composition of the e-liquid or the aerosol and thereby increase the...
  5. CORESTA Congress, Kunming, 2018, Plenary Session, IG 02

    Cigarette Variability Task Force study designs, statistical considerations, initial observations, and limitations

    MORTON M.J.(1); TAYYARAH R.(2); FLORA J.(1)
    (1) Altria Client Services LLC, Richmond, VA, U.S.A.; (2) ITG Brands, Greensboro, North Carolina, U.S.A. [Presented as a representative of the CVAR TF]
    The objective of the Cigarette Variability Task Force (CVAR TF) is to examine commercial cigarette variability through testing of select cigarette smoke and tobacco filler constituents plus select physical characteristics. To meet this objective, the...
  6. CORESTA Congress, Kunming, 2018, Smoke Science/Product Technology Groups, STPOST 63 (also presented at TSRC 2018)

    Challenges and opportunities in cigar science

    SMITH J.H.(1); AUBUCHON S.M.(1); WAGNER K.A.(1); McKINNEY W.J.(1); GILLMAN I.G.(2); STEVENS R.(3)
    (1) Altria Client Services LLC, Richmond, VA, U.S.A.; (2) Enthalpy Analytical, Inc., Henrico, VA, U.S.A.; (3) ITG Brands LLC, Greensboro, NC, U.S.A.
    An independent Cigar Working Group has been formed by interested cigar stakeholders (e.g. manufacturers and testing laboratories). The goals of the Working Group are to explore opportunities for engagement with the Food and Drug Administration (FDA)...